JA
Jeet Anil Ingale
About Jeet Anil Ingale
Data last updated:
Jeet Anil Ingale is a Managing Director at Occules Pharma (Opc) Private Limited (since 2023). Occules Pharma (Opc) Private Limited reported revenue of ₹7.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Occules Pharma (Opc) Private Limited U46497GJ2023OPC141695 | Managing Director | 31 May 2023 | 2023 | ₹7.7 Lakh (FY 2025) | Active |
Board colleagues of Jeet Anil Ingale
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kasamashaha Hasanashaha Shaha | 10294521 | Occules Pharma (Opc) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jeet Anil Ingale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jeet Anil Ingale
Jeet Anil Ingale currently holds 1 directorship: Occules Pharma (Opc) Private Limited (Managing Director, since 31 May 2023, revenue ₹7.7 Lakh (FY 2025)).
Jeet Anil Ingale was first appointed on 31 May 2023 as Managing Director at Occules Pharma (Opc) Private Limited.
The current boards of Jeet Anil Ingale's companies include Kasamashaha Hasanashaha Shaha (Occules Pharma (Opc) Private Limited).